KOCAA
EWTX icon

Knights of Columbus Asset Advisors’s Edgewise Therapeutics EWTX Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.57M Buy
38,641
+227
+0.6% +$7.83K 0.08% 243
2026
Q1 		$1.21M Sell
38,414
-262
-0.7% -$7.55K 0.07% 244
2025
Q4 		$960K Buy
+38,676
New +$776K 0.05% 266

Other funds holding EWTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return

Knights of Columbus Asset Advisors's EWTX Position: Q2 2026 in Review

Knights of Columbus Asset Advisors increased its Edgewise Therapeutics (EWTX) stake by 0.59% in Q2 2026, buying an estimated $7.83K and bringing the position to 38,641 shares worth $1.57M. The position accounts for 0.08% of the portfolio, ranked #243.

Knights of Columbus Asset Advisors first reported a position in EWTX in Q4 2025 and has held it in 3 quarters since. 64 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Knights of Columbus Asset Advisors held 38,641 shares of Edgewise Therapeutics worth $1.57M as of Q2 2026.
  • Knights of Columbus Asset Advisors bought 227 Edgewise Therapeutics shares in Q2 2026, an estimated $7.83K.
  • Edgewise Therapeutics made up 0.08% of Knights of Columbus Asset Advisors's portfolio in Q2 2026, its #243 holding.
  • Knights of Columbus Asset Advisors first reported a position in Edgewise Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 64 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.